Eli Lilly CEO explains White House medication cost deal

Today's a big announcement for Americans who suffer from obesity, overweight. Um, you know, we know that these medicines we've invented like our Zepbound have had many uh breakthroughs preventing chronic disease, but they've been out of reach for too many people because of cost. We really need coverage, and today's announcement is about coverage for seniors.So, uh, we agreed with the Trump administration to enable coverage starting next spring for our medication and others, um, for $50 a month. That's a hug ...